Navigation Links
ev3 Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Date:5/27/2008

PLYMOUTH, Minn., May 27 /PRNewswire/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008 at 11:00 a.m. PT (2:00 p.m. ET and 1:00 p.m. CT). The Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference will be held at the Ritz-Carlton Laguna Niguel in Dana Point, California.

To access the webcast, go to the investors' section of the ev3 Web site at http://www.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
2. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
3. Bioniche Presents Pre-Clinical Research at Two International Conferences
4. VNUS Medical Technologies to Present at FBR Capital Markets 12th Annual Spring Investor Conference
5. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
6. Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008
7. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
8. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
9. Hologic to Present at NASDAQs 21st Investor Program in London
10. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
11. Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/25/2017)... ... 25, 2017 , ... Getting earned media coverage meaningful for Garden Media Group's ... through the year, Garden Media aims to provide material helpful to clients’ goals and ... pitching client’s key messages to gain coveted media placements, Garden Media wows clients ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)...  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company ... in children, today reported financial results for the ... 2016 and provided an update on its corporate ... progress during the fourth quarter of 2016 through ... safety study, and with our lead development candidate, ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets ... Market, 2017-2027" report to their offering. ... The Cell Therapy Manufacturing ... growing market of cell therapy manufacturing and focuses both on ... These therapies are anticipated to emerge as viable alternatives to ...
(Date:3/24/2017)... March 24, 2017  Zymo Research Corp., ... Hamilton Robotics, Inc., who designs, manufactures and ... collaboration that teams Zymo Research,s DNA methylation ... DNA extraction products with Hamilton,s high-throughput automation ... methods for microbiomics and RNA isolation for ...
Breaking Medicine Technology: